Surgical Science Sweden AB (publ) (STO:SUS)
Sweden · Delayed Price · Currency is SEK 33.06
-0.08 (-0.24%)
Jun 16, 2026, 11:20 AM CET
STO:SUS Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, STO:SUS stock has a consensus rating of "Buy" and an average price target of kr 59.80. The average 1-year stock price forecast is 80.88% higher than the current stock price, while the lowest is kr 40.00 (+20.99%) and the highest is kr 88.00 (+166.18%).
Price Target: kr 59.80 (+80.88%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for STO:SUS stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
1.00B
from 992.34M
Increased by 1.12%
Revenue Next Year
1.12B
from 1.00B
Increased by 11.14%
EPS This Year
2.25
from 1.71
Increased by 31.55%
EPS Next Year
2.98
from 2.25
Increased by 32.46%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SEK.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.0B | ||
| Avg | 1.0B | ||
| Low | 987.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.3% | ||
| Avg | 1.1% | ||
| Low | -0.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.92 | ||
| Avg | 2.25 | ||
| Low | 1.51 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 70.8% | ||
| Avg | 31.6% | ||
| Low | -11.7% |